Home > About ActoGeniX > Scientific Advisory Board
ActoGeniX Announces Positive Results From a Phase 1B Study of AG013 for the Prevention of Oral Mucositis in Cancer patients
Dr. Staf Van Reet joins ActoGeniX Board as Chairman
ActoGeniX receives IWT grant for treatment of Clostridium difficile-associated enteric disease
Biotechdag, 23 June 2012
The Biopharmaceutical Conference in Europe, Cannes, 13-15 June 2012
Knowledge for Growth 2012, ICC Gent, 24 May 2012